These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5133607)

  • 1. Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
    Housholder GE; Loo TL
    J Pharmacol Exp Ther; 1971 Nov; 179(2):386-95. PubMed ID: 5133607
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in human and animal tumor tissue.
    Mizuno NS; Humphrey EW
    Cancer Chemother Rep; 1972 Aug; 56(4):465-72. PubMed ID: 5081589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolism of oxaflumazine].
    Boissier JR; Gérardin A; Dumont C
    Ann Pharm Fr; 1972 Dec; 30(12):851-60. PubMed ID: 4148298
    [No Abstract]   [Full Text] [Related]  

  • 4. The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.
    Vogel CL; Denham C; Waalkes TP; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1651-7. PubMed ID: 5457935
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells in culture.
    Gerulath AH; Loo TL
    Biochem Pharmacol; 1972 Sep; 21(17):2335-43. PubMed ID: 4675028
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Biochem Pharmacol; 1970 Jun; 19(6):2043-51. PubMed ID: 5513972
    [No Abstract]   [Full Text] [Related]  

  • 7. Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
    Saunders PP; Chao LY
    Cancer Res; 1974 Oct; 34(10):2464-9. PubMed ID: 4472112
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide.
    Loo TL; Luce JK; Jardine JH; Frei E
    Cancer Res; 1968 Dec; 28(12):2448-53. PubMed ID: 5728154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the fate of the antidepressant amitriptyline in the organism of the rat and man].
    Eschenhof E; Rieder J
    Arzneimittelforschung; 1969 Jun; 19(6):957-66. PubMed ID: 5820041
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary report on the intestinal absorption of acetyldigoxin (Lanatiline) in comparison with digoxin using radioactive labelling substances].
    Buchtela K; Hackl H; Königstein M; Schläger J
    Wien Med Wochenschr; 1968 Feb; 118(5):86-93. PubMed ID: 5664025
    [No Abstract]   [Full Text] [Related]  

  • 11. N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.
    Skibba JL; Beal DD; Ramirez G; Bryan GT
    Cancer Res; 1970 Jan; 30(1):147-50. PubMed ID: 5441073
    [No Abstract]   [Full Text] [Related]  

  • 12. Species differences in the physiological disposition of 3-tritylthio-L-alanine (NSC83265).
    Coffey JJ; Palm PE; Denine EP; Baronowsky PE; Kensler CJ
    Cancer Res; 1971 Dec; 31(12):1908-14. PubMed ID: 5000977
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK; Friedman MA
    Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
    [No Abstract]   [Full Text] [Related]  

  • 14. The absorption of 1,6-dibromo-1,6-didesoxy-d-mannitol in normal and in tumour-bearing rats.
    Csányi E
    Arzneimittelforschung; 1967 Jan; 17(1):52-5. PubMed ID: 5632528
    [No Abstract]   [Full Text] [Related]  

  • 15. [Distribution and excretion of aurantin-Cl4 from intact mice and mice with transplantable tumors].
    Suskova VS; Khasigov PZ; Chernov VA; Karpov VL; Serebriakov NG
    Antibiotiki; 1970 May; 15(5):437-41. PubMed ID: 4193821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].
    Rehbinder D; Deckers W
    Arzneimittelforschung; 1969 Feb; 19(2):169-76. PubMed ID: 5818753
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of 4-diazoimidazole-5-carboxamide in the action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4-(5)carboxamide in Bacillus subtilis.
    Saunders PP; Schultz GA
    Biochem Pharmacol; 1972 Aug; 21(15):2065-76. PubMed ID: 4630320
    [No Abstract]   [Full Text] [Related]  

  • 18. Microsomal metabolism of triazenylimidazoles.
    Hill DL
    Cancer Res; 1975 Nov; 35(11 Pt 1):3106-10. PubMed ID: 241485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide.
    Housholder GE; Loo TL
    Life Sci; 1969 May; 8(9):533-6. PubMed ID: 5791705
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.